Article Information
History
- May 3, 2021.
Article Versions
- Version 1 (April 30, 2021 - 16:25).
- You are currently viewing Version 2 of this article (May 3, 2021 - 13:55).
- Version 3 (May 4, 2021 - 10:19).
- Version 4 (September 9, 2021 - 11:01).
- Version 5 (January 7, 2022 - 09:12).
- View Version 6, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Kathryn Westendorf1,
- Stefanie Žentelis1,
- Denisa Foster2,
- Peter Vaillancourt2,
- Matthew Wiggin1,
- Erica Lovett1,
- Jörg Hendle2,
- Anna Pustilnik2,
- J. Michael Sauder2,
- Lucas Kraft1,
- Yuri Hwang1,
- Robert W. Siegel3,
- Jinbiao Chen3,
- Beverly A. Heinz3,
- Richard E. Higgs3,
- Nicole Kalleward3,
- Kevin Jepson1,
- Rodrigo Goya1,
- Maia A. Smith1,
- David W. Collins1,
- Davide Pellacani1,
- Ping Xiang1,
- Valentine de Puyraimond1,
- Marketa Ricicova1,
- Lindsay Devorkin1,
- Caitlin Pritchard1,
- Aoise O’Neill1,
- Courtney Cohen5,
- John Dye5,
- Kathleen I. Huie5,
- Catherine V. Badger5,
- Darwyn Kobasa6,7,
- Jonathan Audet6,7,
- Joshua J. Freitas2,
- Saleema Hassanali2,
- Ina Hughes2,
- Luis Munoz2,
- Holly C. Palma2,
- Bharathi Ramamurthy2,
- Robert W. Cross7,8,
- Thomas W. Geisbert7,8,
- Iliana Lanz1,
- Lisa Anderson1,
- Payal Sipahimalani1,
- Kizzmekia S. Corbett4,
- Lingshu Wang4,
- Eun Sung Yang4,
- Yi Zhang4,
- Wei Shi4,
- Barney S. Graham4,
- John R. Mascola4,
- Tara L. Fernandez1,
- Carl L. Hansen1,
- Ester Falconer1,
- Bryan E. Jones2,* and
- Bryan C. Barnhart1,*,#
- 1AbCellera Biologics Inc., Vancouver, BC, Canada
- 2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
- 3Eli Lilly and Company, Indianapolis, IN, USA
- 4Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
- 5U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, 21702, USA
- 6National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
- 7University of Manitoba, Winnipeg, Manitoba, Canada
- 8Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA
- ↵*Corresponding authors bo.barnhart{at}abcellera.com, jones_bryan_edward{at}lilly.com